Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
9.99
-0.10 (-0.99%)
Dec 5, 2025, 4:00 PM EST - Market closed
Aligos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 61 | 148 | 50 | 41 | 506 | 1,054 | |
| Market Cap Growth | -17.68% | 197.20% | 21.95% | -91.94% | -52.00% | - | |
| Enterprise Value | -32 | 82 | -9 | -88 | 276 | 1,180 | |
| Last Close Price | 9.99 | 39.84 | 16.60 | 23.82 | 296.75 | 691.25 | |
| PS Ratio | 33.44 | 37.48 | 3.20 | 2.93 | 116.05 | - | |
| PB Ratio | 0.86 | -5.10 | 0.54 | 0.39 | 2.74 | 4.79 | |
| P/TBV Ratio | 0.86 | - | 0.54 | 0.39 | 2.74 | 4.79 | |
| EV/Sales Ratio | - | 20.81 | - | - | 63.34 | - | |
| Debt / Equity Ratio | 0.08 | -0.29 | 0.12 | 0.12 | 0.08 | 0.06 | |
| Asset Turnover | 0.03 | 0.04 | 0.10 | 0.07 | 0.02 | - | |
| Quick Ratio | 4.51 | 2.62 | 5.68 | 3.80 | 4.90 | 8.04 | |
| Current Ratio | 4.70 | 2.86 | 5.90 | 4.03 | 5.25 | 8.26 | |
| Return on Equity (ROE) | -141.82% | -415.84% | -89.48% | -66.55% | -63.41% | -64.37% | |
| Return on Assets (ROA) | -54.70% | -50.29% | -36.63% | -31.92% | -32.04% | -29.70% | |
| Return on Capital (ROIC) | -79.06% | -134.89% | -49.73% | -38.64% | -37.11% | -33.55% | |
| Return on Capital Employed (ROCE) | -98.80% | -184.40% | -68.50% | -85.90% | -65.30% | -41.60% | |
| Earnings Yield | -140.65% | -88.73% | -176.22% | -235.41% | -25.37% | -10.30% | |
| FCF Yield | -129.38% | -54.69% | -158.81% | -196.90% | -23.04% | -7.24% | |
| Buyback Yield / Dilution | -48.60% | -144.38% | -50.10% | -7.12% | -299.03% | -397.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.